Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Nov 03, 9:37 PMHealthpeak raises 2026 FFO guidance again on strong lab, outpatient and senior housing trends
Index
S&P 500
Market Cap
14.36B
Enterprise Value
26.36B
Income
377.12M
Sales
3.06B
Book/sh
11.41
Cash/sh
0.86
Employees
411
IPO
Jul 19, 2013
P/E
37.40
Forward P/E
100.41
PEG
2.35
P/S
4.68
P/B
1.78
P/C
23.70
P/FCF
12.62
EV/EBITDA
15.97
EV/Sales
8.60
Quick Ratio
14.01
Current Ratio
14.01
Debt/Eq
1.23
LT Debt/Eq
1.22
Option/Short
Yes / Yes
EPS (ttm)
0.54
EPS next Y
0.20
EPS next Q
0.04
EPS this Y
336.59%
EPS next Y
-53.65%
EPS next 5Y
42.64%
EPS past 3/5Y
-52.08% -
Sales past 3/5Y
11.05% 11.40%
EPS Y/Y TTM
1063.30%
Sales Y/Y TTM
9.42%
EPS Q/Q
114.70%
Sales Q/Q
16.29%
Insider Own
0.31%
Insider Trans
-0.50%
Inst Own
98.74%
Inst Trans
-4.78%
ROA
1.80%
ROE
4.88%
ROIC
2.16%
Gross Margin
19.79%
Oper. Margin
16.86%
Profit Margin
12.30%
SMA20
6.36%
SMA50
2.78%
SMA200
5.97%
Trades
Shs Outstand
689.54M
Shs Float
687.38M
52W High
22.95 -11.47%
52W Low
15.70 29.41%
Volatility
2.65% 2.45%
ATR (14)
0.48
RSI (14)
62.29
Beta
0.99
Rel Volume
0.01
Avg Volume
5.53M
Volume
2,382
Perf Week
7.27%
Perf Month
8.88%
Perf Quarter
-5.10%
Perf Half Y
3.34%
Perf YTD
26.35%
Perf Year
13.70%
Perf 3Y
20.95%
Perf 5Y
-38.51%
Perf 10Y
-28.67%
Prev Close
20.17
Price
20.32
Change %
0.73%
Consensus
Buy
Avg. Price Target
$22.24
Implied Upside
+9.5%
Analysts17incl. previous ratings
Rating Distribution5 Buy · 12 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jul 07, 2026Initiated
BCS logoBBarclays
Equal Weight$23+13.2%
Jun 17, 2026Resumed
RJF logoRRaymond James
Mkt Perform
Jun 11, 2026Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight$22+8.3%
May 11, 2026Downgrade
EVR logoEEvercore ISI
Outperform → In-line$21+3.4%
Apr 20, 2026Initiated
UBS logoUUBS
Neutral$17-16.3%
Feb 05, 2026Downgrade
AArgus
Buy → Hold
Jan 09, 2026Initiated
GS logoGGoldman
Neutral$17-16.3%
Dec 16, 2025Downgrade
JEF logoJJefferies
Buy → Hold$17-16.3%
Oct 01, 2025Initiated
CCantor Fitzgerald
Neutral$20-1.6%
Sep 15, 2025Upgrade
RJF logoRRaymond James
Mkt Perform → Outperform$20-1.6%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bohn Scott RCDO and Head of LabMay 12 '26Sale19.4510,989213,7407,636May 13 04:30 PM
Bohn Scott ROfficerMay 12 '26Proposed Sale19.4510,989213,741May 12 04:07 PM
Healthpeak Properties, Inc. engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. It operates through the following segments: Outpatient Medical, Lab, and Senior Housing. The Outpatient Medical segment includes outpatient medical buildings and hospitals. The Lab segment consists of laboratory and office space. The Senior Housing segment includes life plan communities and unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets and loans receivable. The company was founded in March 1985 and is headquartered in Denver, CO.
PresidentMr. Scott M. Brinker
Chief Financial OfficerMr. Kelvin O. Moses
Chief Investment OfficerMr. Adam G. Mabry
Executive VPMs. Tracy A. Porter
Chief Development Officer & Head of LabMr. Scott R. Bohn